These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26353781)

  • 1. Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year.
    Chamberlain JJ; Dopita D; Gilgen E; Neuman A
    J Diabetes Sci Technol; 2015 Sep; 10(2):383-8. PubMed ID: 26353781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining clinical and psychological benefits and barriers with continuous glucose monitoring therapy.
    Halford J; Harris C
    Diabetes Technol Ther; 2010 Mar; 12(3):201-5. PubMed ID: 20151770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives.
    Pickup JC; Ford Holloway M; Samsi K
    Diabetes Care; 2015 Apr; 38(4):544-50. PubMed ID: 25552422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
    Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
    Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study.
    Pazos-Couselo M; García-López JM; González-Rodríguez M; Gude F; Mayán-Santos JM; Rodríguez-Segade S; Rodríguez-García J; Casanueva F
    Can J Diabetes; 2015 Oct; 39(5):428-33. PubMed ID: 26254702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?
    Fabris C; Patek SD; Breton MD
    J Diabetes Sci Technol; 2015 Aug; 10(1):50-9. PubMed ID: 26275643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
    Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D
    J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-Time Continuous Glucose Monitoring Facilitates Feelings of Safety in Older Adults With Type 1 Diabetes: A Qualitative Study.
    Litchman ML; Allen NA
    J Diabetes Sci Technol; 2017 Sep; 11(5):988-995. PubMed ID: 28376647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes.
    Jabbour G; Bragazzi NL
    Front Endocrinol (Lausanne); 2021; 12():722123. PubMed ID: 34557162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Glucose Monitoring in Patients with Type 1 Diabetes and Impaired Awareness of Hypoglycemia: Also Effective in Patients with Psychological Distress?
    van Beers CAJ; de Wit M; Kleijer SJ; Geelhoed-Duijvestijn PH; DeVries JH; Kramer MHH; Diamant M; Serné EH; Snoek FJ
    Diabetes Technol Ther; 2017 Oct; 19(10):595-599. PubMed ID: 28836833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Continuous Glucose Monitoring Accuracy Between Abdominal and Upper Arm Insertion Sites.
    Steineck IIK; Mahmoudi Z; Ranjan A; Schmidt S; Jørgensen JB; Nørgaard K
    Diabetes Technol Ther; 2019 May; 21(5):295-302. PubMed ID: 30994362
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.
    Kusunoki Y; Katsuno T; Nakae R; Watanabe K; Akagami T; Ochi F; Tokuda M; Murai K; Miuchi M; Miyagawa J; Namba M
    Diabetes Res Clin Pract; 2015 May; 108(2):342-9. PubMed ID: 25779865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sydney Diabetes centre's experience of the Australian Government's roll out of subsidised continuous glucose monitoring for children with type 1 diabetes mellitus.
    Sandy JL; Nyunt O; Woodhead HJ; Youde LS; Ramjan KA; Jack MM; Lim L; Shepherd M; Marshall A; Townsend N; Wilson S; Duke SA; Slavich E; Hameed S
    J Paediatr Child Health; 2019 Sep; 55(9):1056-1062. PubMed ID: 30565355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.